Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

Read more

Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Read more

Future and Challenges of the Pharmaceutical Industry

14 November 2019

Open

Interview: Adrian van den Hoven, Director General of Medicines for Europe

8 January 2019

Over the last ten years, generic medicines have increased access […]

Read more

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Read more

Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive

13 September 2018

Open

Value-added medicines: how repurposed medicines bring value to patients and pharmacists

21 December 2017

Open

Manufacturing cost transparency could combat pricing criticism, says expert

2 November 2017

Open

Europe needs change to drive added value

15 September 2017

Open

European report calms common concerns

15 September 2017

Open

Subscribe to our newsletter